Lokon Pharma AB, a company developing next-generation cancer therapeutics, has selected Biovian Oy as a CDMO partner for GMP manufacturing of LOAd703 for a pivotal randomized study. The uniquely engineered LOAd703 oncolytic virus is currently …
Tenboron Ltd, the developer of a novel boron carrier for use in Boron Neutron Capture Therapy (BNCT), has selected Biovian Oy as a CDMO partner for GMP manufacturing of their drug candidate for phase I …
